Pfizer Inc.
SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS

Last updated:

Abstract:

Provided herein are substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.

Status:
Application
Type:

Utility

Filling date:

23 Mar 2021

Issue date:

7 Oct 2021